The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.
This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.
Sarah D. Meskill, MD1; Gerard Meskill, MD1; Asim Roy, MD2; Adrian Santamaria, MD3; Robyn Porpiglio, FNP-C4; Oktai Mamedov, MD5; Sally Ibrahim, MD6,7; Omavi Bailey, MD8; Richard K. Bogan, MD9,10; Laura B. Herpel, MD10,11; Matthew Davis, MD12; Jeremy D. McConnell, MD13; Gretchen S. Richards, MS14; Brian Abaluck, MD14; Jennifer Gudeman, PharmD15,a
1Tricoastal Narcolepsy and Sleep Disorder Center, Sugar Land, TX, USA; 2Ohio Sleep Medicine Institute, Dublin, OH, USA; 3Northwest Houston Neurology & Comprehensive Sleep Medicine Center, Houston, TX, USA; 4Ghaly Sleep Management Services, LLC, Syracuse, NY, USA; 5Comprehensive Sleep Center, East Lansing, MI, USA; 6University Hospitals Cleveland Medical Center,Cleveland, OH, USA; 7Case Western Reserve University School of Medicine, Cleveland, OH, USA; 8Biorhythms, El Paso, TX, USA; 9University of South Carolina School of Medicine, Columbia, SC, USA; 10Medical University of South Carolina, Charleston, SC, USA; 11Bogan Sleep Consultants, Columbia, SC, USA; 12Patient First MD, Middletown, NJ, USA; 13Florida Sleep Specialists, Bradenton, FL, USA; 14Alkermes, Inc., Waltham, MA, USA*; 15Avadel Pharmaceuticals, Chesterfield, MO, USA; aAt the time of the study
